stephen B Hanauer

2022

Reviewing the Use of Vedolizumab for the Treatment of Patients With Crohn's Disease

Hanauer, S. B., May 2022, In: Gastroenterology and Hepatology. 18, 5, p. 287-290 4 p.

Research output: Contribution to journal › Comment/debate › peer-review

2020

Management of IBD patients during the COVID-19 pandemic

Hanauer, S. B. & Lichtenstein, G. R., Nov 2020, In: Gastroenterology and Hepatology. 16, 11, p. 577-580 4 p.

Research output: Contribution to journal › Comment/debate › peer-review

The role of ultrasound in the management of inflammatory bowel disease

Hanauer, S. B. & Wilson, S. R., Dec 2020, In: Gastroenterology and Hepatology. 16, 12, p. 640-643 4 p.

Research output: Contribution to journal › Comment/debate › peer-review

2017

Combination therapy for inflammatory bowel disease

Hanauer, S. B., May 2017, In: Gastroenterology and Hepatology. 13, 5, p. 296-298 3 p.

Research output: Contribution to journal › Comment/debate › peer-review

6 Scopus citations

Common chronic complications following inflammatory bowel disease surgery

Hanauer, S. B., Strong, S. A. & Hines, J. R., Apr 2017, In: Gastroenterology and Hepatology. 13, 4, p. 234-237 4 p.

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Issue Highlights

Hanauer, S. B., Feb 1 2017, In: Clinical Gastroenterology and Hepatology. 15, 2, p. 161-163 3 p.

Research output: Contribution to journal › Comment/debate › peer-review

Targeting Crohn's disease

Hanauer, S. B., Dec 23 2017, In: The Lancet. 390, 10114, p. 2742-2744 3 p.

Research output: Contribution to journal › Comment/debate › peer-review

Targeting interleukin 23 for Crohn's disease: finding the right drug for the right patient

Hanauer, S. B., Apr 29 2017, In: The Lancet. 389, 10080, p. 1671-1672 2 p.

Research output: Contribution to journal › Comment/debate › peer-review

2016

Issue Highlights

Hanauer, S. B., Jun 1 2016, In: Clinical Gastroenterology and Hepatology. 14, 6, p. 783-784 2 p.

Research output: Contribution to journal › Comment/debate › peer-review

Open Access

2015

Issue highlights

Hanauer, S. B., Mar 1 2015, In: Clinical Gastroenterology and Hepatology. 13, 3, p. 413-415 3 p.

Research output: Contribution to journal › Comment/debate › peer-review

Issue Highlights

Hanauer, S. B., Oct 1 2015, In: Clinical Gastroenterology and Hepatology. 13, 10, p. 1709-1710 2 p., 54416.

Research output: Contribution to journal › Comment/debate › peer-review

New targets for small molecules in inflammatory bowel disease

Hanauer, S. B. & Sandborn, W. J., May 1 2015, In: Gastroenterology and Hepatology. 11, 5, p. 338-340 3 p.

Research output: Contribution to journal › Comment/debate › peer-review

18 Scopus citations

Pregnancy concerns in women with inflammatory bowel disease

Hanauer, S. B. & Mahadevan, U., Apr 1 2015, In: Gastroenterology and Hepatology. 11, 4, p. 273-275 3 p.

Research output: Contribution to journal › Comment/debate › peer-review

4 Scopus citations

Targeting the preclinical phase of inflammatory bowel disease

Hanauer, S. B. & Colombel, J. F., Oct 2015, In: Gastroenterology and Hepatology. 11, 10, p. 711-713 3 p.

Research output: Contribution to journal › Comment/debate › peer-review

6 Scopus citations

2014

Erratum: P-147 Clinical efficacy of certolizumab pegol in patients with Crohn's disease based on moderate versus severe activity in the PRECiSE-2 trial (Inflammatory Bowel Diseases (2013) 19 (S83))

Hanauer, S., Dubinsky, M., Coarse, J. & Rubin, D., Feb 2014, In: Inflammatory bowel diseases. 20, 2, p. E9

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Issue Highlights

Hanauer, S. B., Aug 2014, In: Clinical Gastroenterology and Hepatology. 12, 8, p. 1205-1207 3 p.

Research output: Contribution to journal › Comment/debate › peer-review

Open Access

2013

Issue Highlights

Hanauer, S. B., Apr 2013, In: Clinical Gastroenterology and Hepatology. 11, 4, p. 323 1 p.

Research output: Contribution to journal › Comment/debate › peer-review

Issue Highlights

Hanauer, S. B., Dec 2013, In: Clinical Gastroenterology and Hepatology. 11, 12, p. 1525-1526 2 p.

Research output: Contribution to journal › Comment/debate › peer-review

2012

Can we treat ulcerative colitis with nutritional supplements?

Annunziata, M. L. & Hanauer, S., Feb 2012, In: Alimentary Pharmacology and Therapeutics. 35, 4, p. 485-486 2 p.

Research output: Contribution to journal › Comment/debate › peer-review

Open Access

1 Scopus citations

Commentary: Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with ulcerative colitis

Kaufman, A. B. & Hanauer, S. B., Jul 2012, In: Alimentary Pharmacology and Therapeutics. 36, 2, p. 199-200 2 p.

Research output: Contribution to journal › Comment/debate › peer-review

Open Access

1 Scopus citations

Issue Highlights

Hanauer, S. B., Sep 2012, In: Clinical Gastroenterology and Hepatology. 10, 9, p. 953 1 p.

Research output: Contribution to journal › Comment/debate › peer-review

Management of inflammatory bowel disease: Past, present and future

Keyashian, K., Annunziata, M. L., Sakuraba, A. & Hanauer, S., May 1 2012, In: Expert Review of Clinical Immunology. 8, 4, p. 303-305 3 p.

Research output: Contribution to journal › Comment/debate › peer-review

8 Scopus citations

2011

Erratum: The London position statement of the world congress of gastroenterology on biological therapy for IBD with the European crohn's and colitis organization: When to start, when to stop, which drug to choose, and how to predict response (American Journal of Gastroenterology (2010) 105 (2551-2561) DOI: 10.1038/ ajg.2010.372)

D'Haens, G. R., Panaccione, R., Higgins, P. D. R., Vermeire, S., Gassull, M., Chowers, Y., Hanauer, S. B., Herfarth, H., Hommes, D. W., Kamm, M., Löfberg, R., Quary, A., Sands, B., Sood, A., Watermayer, G., Lashner, B., Lémann, M., Plevy, S., Reinisch, W. & Schreiber, S. & 7 others, Siegel, C., Targan, S., Watanabe, M., Feagan, B., Sandborn, W. J., Colombel, J. F. & Travis, S., Feb 1 2011, In: American Journal of Gastroenterology. 106, 2, 1 p.

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Erratum: Clinical trial: Impact of prior infliximab therapy on the clinical response to certolizumab pegol maintenance therapy for Crohn's disease (Aliment Pharmacol Ther (2010) 32 (384-393))

Hanauer, S. B., Dec 2011, In: Alimentary Pharmacology and Therapeutics. 34, 11-12, p. 1356 1 p.

Research output: Contribution to journal › Comment/debate › peer-review

Open Access

2009

Management of C. difficile infection in IBD

Binion, D. G. & Hanauer, S. B., Apr 2009, In: Gastroenterology and Hepatology. 5, 4, p. 253-256 4 p.

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

2008

Commentary

Hanauer, S. B., Aug 2008, In: Gastroenterology and Hepatology. 4, 8 SUPPL. 15, p. 13-14 2 p.

Research output: Contribution to journal › Comment/debate › peer-review

2006

Continuing Medical Education Exam 3: February 2006 - Human anti-tumor necrosis factor monoclonal antibody (adalimumab)in Crohn's disease: The CLASSIC-I trial

Hanauer, S. B., Feb 2006, In: Gastroenterology. 130, 2, p. 591 1 p.

Research output: Contribution to journal › Comment/debate › peer-review

2005

Erratum: Superior mesenteric vein thrombosis after colectomy in a patient with Crohn's disease (Nature Clinical Practice Gastroenterology and Hepatology (2005) vol. 2 (281-285) 10.1038/ncpgasthep0195)

Ross, A. S., Gasparaitis, A., Hurst, R., Hanauer, S. B. & Rubin, D. T., Oct 2005, In: Nature Clinical Practice Gastroenterology and Hepatology. 2, 10, p. 492 1 p.

Research output: Contribution to journal › Comment/debate › peer-review

Open Access

2003

Treatment of ulcerative colitis with balsalazide: response to Drs Johnson, Green, and Pruitt.

Hanauer, S. B., Mar 2003, In: The American journal of gastroenterology. 98, 3, p. 697-698 2 p.

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

2000

Infliximab et maladie de Crohn: Repeter les injections pour maintenir la remission?

Translated title of the contribution: Infliximab and Crohn's disease: Should injections be repeated to maintain remission?Bourreille, A., Rutgeerts, P., D'Haens, G., Targan, S., Vasiliauskas, E., Hanauer, S. B. & Present, D. H., 2000, In: Hepato-Gastro. 7, 4, p. 305-306 2 p.

Research output: Contribution to journal › Comment/debate › peer-review

1999